- Home
- Publications
- Publication Search
- Publication Details
Title
Viral Vector Vaccines against Bluetongue Virus
Authors
Keywords
-
Journal
Microorganisms
Volume 9, Issue 1, Pages 42
Publisher
MDPI AG
Online
2020-12-25
DOI
10.3390/microorganisms9010042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
- (2020) Wakako Furuyama et al. npj Vaccines
- Economic Impact of a Bluetongue Serotype 8 Epidemic in Germany
- (2020) Jörn Gethmann et al. Frontiers in Veterinary Science
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
- (2020) Neeltje van Doremalen et al. Science Advances
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
- (2020) Simon P. Graham et al. npj Vaccines
- A protective bivalent vaccine against Rift Valley fever and bluetongue
- (2020) Eva Calvo-Pinilla et al. npj Vaccines
- Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
- (2020) Sergio Utrilla-Trigo et al. Vaccines
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge
- (2020) Shipo Wu et al. Nature Communications
- Novel Putative Bluetongue Virus Serotype 29 Isolated from Inapparently Infected Goat in Xinjiang of China
- (2020) Heng Yang et al. Transboundary and Emerging Diseases
- Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge
- (2020) Sandra Moreno et al. PLoS Neglected Tropical Diseases
- A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters
- (2019) Neeltje van Doremalen et al. PLoS Neglected Tropical Diseases
- Characterization of bluetongue virus serotype 28
- (2019) Velizar Bumbarov et al. Transboundary and Emerging Diseases
- African Horse Sickness: A Review of Current Understanding and Vaccine Development
- (2019) Susan J Dennis et al. Viruses-Basel
- Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara
- (2019) Alejandro Marín-López et al. VACCINE
- Vector Competence of Italian Populations of Culicoides for Some Bluetongue Virus Strains Responsible for Recent Northern African and European Outbreaks
- (2019) Valentina Federici et al. Viruses-Basel
- Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
- (2019) Naif Khalaf Alharbi et al. Scientific Reports
- A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease
- (2019) Rafael Kroon Campos et al. Pathogens
- State‐of‐the‐art human adenovirus vectorology for therapeutic approaches
- (2019) Jian Gao et al. FEBS LETTERS
- Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle
- (2019) Mahder Teffera et al. Frontiers in Veterinary Science
- Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models
- (2018) Qiang Guo et al. JOURNAL OF INFECTIOUS DISEASES
- CD8 T CELL RESPONSES TO AN IMMUNODOMINANT EPITOPE WITHIN THE NON-STRUCTURAL PROTEIN NS1 PROVIDES WIDE IMMUNOPROTECTION AGAINST BLUETONGUE VIRUS IN IFNAR(-/-) MICE
- (2018) Alejandro Marín-López et al. JOURNAL OF VIROLOGY
- Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors
- (2018) César López-Camacho et al. Nature Communications
- A VSV-based Zika virus vaccine protects mice from lethal challenge
- (2018) Jackson Emanuel et al. Scientific Reports
- Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
- (2018) L. Coughlan et al. EBioMedicine
- The virulence of different Vaccinia virus strains is directly proportional to their ability in down modulating specific cell-mediated immune compartments in vivo.
- (2018) Lorena F. D. de Freitas et al. JOURNAL OF VIROLOGY
- A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding
- (2018) Bruno Hernáez et al. Nature Communications
- Establishing China's National Standard for the Recombinant Adenovirus Type 5 Vector–Based Ebola Vaccine (Ad5-EBOV) Virus Titer
- (2018) Yuhua Li et al. Human Gene Therapy Clinical Development
- Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Feng-Cai Zhu et al. LANCET
- ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
- (2017) Naif Khalaf Alharbi et al. VACCINE
- Safety and immunogenicity of mammalian cell derived and Modified Vaccinia Ankara vectored African swine fever subunit antigens in swine
- (2017) Jaime Lopera-Madrid et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Jing-Xin Li et al. Lancet Global Health
- Multivalent and Multipathogen Viral Vector Vaccines
- (2016) Katharina B. Lauer et al. Clinical and Vaccine Immunology
- Bluetongue virus serotype 27: detection and characterization of two novel variants in Corsica, France
- (2016) Claudia Schulz et al. JOURNAL OF GENERAL VIROLOGY
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral vectors as vaccine carriers
- (2016) Hildegund CJ Ertl Current Opinion in Virology
- Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
- (2016) George M. Warimwe et al. Scientific Reports
- DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1
- (2015) Junping Li et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses
- (2015) Charles J. Russell et al. Expert Review of Vaccines
- Characterization of a second open reading frame in genome segment 10 of bluetongue virus
- (2015) Meredith Stewart et al. JOURNAL OF GENERAL VIROLOGY
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- Application of Bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2
- (2015) Femke Feenstra et al. VACCINE
- Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses
- (2015) Verónica Martín et al. PLoS One
- VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(−/−) mice
- (2014) Alejandro Marín-López et al. ANTIVIRAL RESEARCH
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses
- (2014) Michele Tameris et al. PLoS One
- Expression of VP7, a Bluetongue Virus Group Specific Antigen by Viral Vectors: Analysis of the Induced Immune Responses and Evaluation of Protective Potential in Sheep
- (2014) Coraline Bouet-Cararo et al. PLoS One
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins
- (2014) Blair L. DeBuysscher et al. VACCINE
- Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen
- (2014) N. Oreshkova et al. VACCINE
- Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle
- (2014) Jenna Anderson et al. VACCINE
- Complex Correlates of Protection After Vaccination
- (2013) S. A. Plotkin CLINICAL INFECTIOUS DISEASES
- Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
- (2013) G. L. Smith et al. JOURNAL OF GENERAL VIROLOGY
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
- (2013) Tamara Kusay Jabbar et al. PLoS One
- Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus
- (2013) Stefan J. Halbherr et al. PLoS One
- Experimental infection of white-tailed deer (Odocoileus virginianus) with Northern European bluetongue virus serotype 8
- (2013) Barbara S. Drolet et al. VETERINARY MICROBIOLOGY
- Understanding and altering cell tropism of vesicular stomatitis virus
- (2013) Eric Hastie et al. VIRUS RESEARCH
- Recombinant vaccines against bluetongue virus
- (2013) Eva Calvo-Pinilla et al. VIRUS RESEARCH
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- Full Genome Sequencing and Genetic Characterization of Eubenangee Viruses Identify Pata Virus as a Distinct Species within the Genus Orbivirus
- (2012) Manjunatha N. Belaganahalli et al. PLoS One
- An Equine Herpesvirus Type 1 (EHV-1) Expressing VP2 and VP5 of Serotype 8 Bluetongue Virus (BTV-8) Induces Protection in a Murine Infection Model
- (2012) Guanggang Ma et al. PLoS One
- Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
- (2012) Eva Calvo-Pinilla et al. PLoS One
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- Myxomavirus as a vector for the immunisation of sheep: Protection study against challenge with bluetongue virus
- (2012) Sokunthea Top et al. VACCINE
- Generation of Replication-Defective Virus-Based Vaccines That Confer Full Protection in Sheep against Virulent Bluetongue Virus Challenge
- (2011) E. Matsuo et al. JOURNAL OF VIROLOGY
- Rift Valley Fever: Recent Insights into Pathogenesis and Prevention
- (2011) H. Boshra et al. JOURNAL OF VIROLOGY
- Infection of Nonhost Species Dendritic Cells In Vitro with an Attenuated Myxoma Virus Induces Gene Expression That Predicts Its Efficacy as a Vaccine Vector
- (2011) S. Top et al. JOURNAL OF VIROLOGY
- The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens
- (2011) C. E. Gomez et al. JOURNAL OF VIROLOGY
- Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen
- (2011) Valentina Franceschi et al. VACCINE
- Identification and Characterization of a Novel Non-Structural Protein of Bluetongue Virus
- (2011) Maxime Ratinier et al. PLoS Pathogens
- Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine
- (2010) R. K. Soi et al. Clinical and Vaccine Immunology
- A Vesicular Stomatitis Virus-Based Hepatitis B Virus Vaccine Vector Provides Protection against Challenge in a Single Dose
- (2010) M. A. Cobleigh et al. JOURNAL OF VIROLOGY
- Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep
- (2010) Coraline Bouet-Cararo et al. VACCINE
- Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseases
- (2010) N. James MacLachlan et al. VETERINARY RESEARCH
- Cellular Targeting of Engineered Heterologous Antigens Is a Determinant Factor for Bovine Herpesvirus 4-Based Vaccine Vector Development
- (2009) G. Donofrio et al. Clinical and Vaccine Immunology
- The Pathology and Pathogenesis of Bluetongue
- (2009) N.J. Maclachlan et al. JOURNAL OF COMPARATIVE PATHOLOGY
- The Interferon System and Vaccinia Virus Evasion Mechanisms
- (2009) Beatriz Perdiguero et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Epidemiologic characteristics of bluetongue virus serotype 8 laboratory-confirmed outbreaks in The Netherlands in 2007 and a comparison with the situation in 2006
- (2009) Armin R.W. Elbers et al. PREVENTIVE VETERINARY MEDICINE
- Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infection
- (2009) Eva Calvo-Pinilla et al. VACCINE
- Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus
- (2009) Alan J. Guthrie et al. VACCINE
- Functional Mapping of Bluetongue Virus Proteins and Their Interactions with Host Proteins During Virus Replication
- (2008) Polly Roy CELL BIOCHEMISTRY AND BIOPHYSICS
- T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus
- (2008) M. Habjan et al. JOURNAL OF GENERAL VIROLOGY
- Safety and immunogenicity of myxoma virus as a new viral vector for small ruminants
- (2008) B. Pignolet et al. JOURNAL OF GENERAL VIROLOGY
- Field observations during the bluetongue serotype 8 epidemic in 2006
- (2008) Armin R.W. Elbers et al. PREVENTIVE VETERINARY MEDICINE
- A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment
- (2008) Carrie A. Batten et al. VIRUS RESEARCH
- Vaccines against bluetongue in Europe
- (2007) Giovanni Savini et al. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
- Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications
- (2007) Zachary C. Hartman et al. VIRUS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started